CXCL10 and breast angiosarcoma: Analysis of the data obtained from the SOMAscan assay performed on serum samples obtained from patients with BA enrolled in the ChiLDReN-sponsored PROBE trial reveal significantly higher levels of CXCL10 when compared with IHC and normal control groups (38).